Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin)

NCT00505648 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Side effects valuation

Conditions

Drug Hypersensitivity

Interventions

DRUG: Tegeline®

Sponsor

University Hospital, Rouen